Regeneron Pharmaceuticals, Inc.REGN

Regeneron Pharmaceuticals, Inc. (REGN): trades by Congress and the executive branch

Every trade in Regeneron Pharmaceuticals, Inc. that a representative, a senator, the President or a senior official disclosed since 2014, newest report first. Each is read from the filer’s periodic transaction report and linked to it.

Latest report Sep 22, 2026 · Source · RSS feed

Trades disclosed
121since 2014
Members
27
Purchases / sales
51 / 70
Typical days to public
31median
Public after 45 days
12of 106 dated trades by Congress

Congress trade alerts · REGN · free

Get an email when anyone in Congress trades Regeneron Pharmaceuticals, Inc.

Each new disclosure of a trade in the stock by a representative, a senator, the President or a senior official, with the filing.

An email when a member of Congress or the executive branch files a trade in REGN, with the filing. Unsubscribe in one click.

Transactions

Every REGN trade disclosed since 2014, newest report first
MemberAssetTypeAmountTrade dateLagPublicFiling
Donald TrumpPresidentREGNRegeneron Pharmaceuticals, Inc.Buy$50K–$100KJul 23, 202661dSep 22PDF
Donald TrumpPresidentREGNRegeneron Pharmaceuticals, Inc.Buy$1K–$15KJul 17, 202667dSep 22PDF
Donald TrumpPresidentREGNRegeneron Pharmaceuticals, Inc.Sell$1K–$15KJun 16, 202667dAug 22PDF
Donald TrumpPresidentREGNRegeneron Pharmaceuticals, Inc.Sell$100K–$250KJun 12, 202671dAug 22PDF
Alan ArmstrongR-OKSenateREGNRegeneron Pharmaceuticals, Inc.Buy$1K–$15KMar 27, 2026116dJul 21Report
Rohit KhannaD-CACA17REGNRegeneron Pharmaceuticals, Inc. · Dependent childSell$1K–$15KJun 2, 202634dJul 6PDF
Donald TrumpPresidentREGNRegeneron Pharmaceuticals, Inc.Sell$1K–$15KMay 18, 202644dJul 1PDF
Donald TrumpPresidentREGNRegeneron Pharmaceuticals, Inc.Buy$100K–$250KMay 11, 202651dJul 1PDF
Donald TrumpPresidentREGNRegeneron Pharmaceuticals, Inc.Buy$15K–$50KApr 27, 202665dJul 1PDF
Donald TrumpPresidentREGNRegeneron Pharmaceuticals, Inc.Buy$1K–$15KApr 17, 202675dJul 1PDF
Donald TrumpPresidentREGNRegeneron Pharmaceuticals, Inc.Buy$1K–$15KApr 15, 202677dJul 1PDF
Gilbert CisnerosD-CACA31REGNRegeneron Pharmaceuticals, Inc.Sell$1K–$15KMay 15, 202624dJun 8PDF
Donald TrumpPresidentREGNRegeneron Pharmaceuticals, Inc.Buy$15K–$50Kdate not readunclearMay 14PDF
Julia LetlowR-LALA05REGNRegeneron Pharmaceuticals, Inc.Buy$1K–$15KFeb 12, 202628dMar 12PDF
Bryan BedfordAdministrator, Federal Aviation Administration, Department of TransportationREGNRegeneron Pharmaceuticals, Inc.Sell$15K–$50KSep 10, 2025100dDec 19PDF
Gilbert CisnerosD-CACA31REGNRegeneron Pharmaceuticals, Inc.Buy$1K–$15KNov 18, 202527dDec 15PDF
Bryan BedfordAdministrator, Federal Aviation Administration, Department of TransportationREGNRegeneron Pharmaceuticals, Inc.Buy$1K–$15KJul 11, 2025139dNov 27PDF
Rob BresnahanR-PAPA08REGNRegeneron Pharmaceuticals, Inc.Buy$1K–$15KMay 15, 202525dJun 9PDF
Byron DonaldsR-FLFL19REGNRegeneron Pharmaceuticals, Inc.Sell$1K–$15KApr 10, 202544dMay 24PDF
Byron DonaldsR-FLFL19REGNRegeneron Pharmaceuticals, Inc. · SpouseSell$1K–$15KApr 10, 202544dMay 24PDF
Julie JohnsonD-TXTX32REGNRegeneron Pharmaceuticals, Inc. · JointSell$1K–$15KApr 1, 202543dMay 14PDF
Rob BresnahanR-PAPA08REGNRegeneron Pharmaceuticals, Inc.Sell$1K–$15KApr 8, 202530dMay 8PDF
Jefferson ShreveR-ININ06REGNRegeneron Pharmaceuticals, Inc.Sell$15K–$50KApr 7, 202531dMay 8PDF
Rob BresnahanR-PAPA08REGNRegeneron Pharmaceuticals, Inc.Sell$1K–$15KFeb 25, 202530dMar 27PDF
Julie JohnsonD-TXTX32REGNRegeneron Pharmaceuticals, Inc. · JointSell$1K–$15KFeb 12, 202528dMar 12PDF
Julie JohnsonD-TXTX32REGNRegeneron Pharmaceuticals, Inc. · JointBuy$1K–$15KJan 15, 202528dFeb 12PDF
Josh GottheimerD-NJNJ05REGNRegeneron Pharmaceuticals, Inc. · JointSell$1K–$15KJan 24, 202517dFeb 10PDF
Jonathan JacksonD-ILIL01REGNRegeneron Pharmaceuticals, Inc. · JointSell$15K–$50KNov 13, 202429dDec 12PDF
Jonathan JacksonD-ILIL01REGNRegeneron Pharmaceuticals, Inc. · JointSell$1K–$15KNov 1, 202441dDec 12PDF
Josh GottheimerD-NJNJ05REGNRegeneron Pharmaceuticals, Inc. · JointSell$1K–$15KNov 29, 20246dDec 5PDF
Josh GottheimerD-NJNJ05REGNRegeneron Pharmaceuticals, Inc. · JointSell$1K–$15KNov 19, 202416dDec 5PDF
Greg LandsmanD-OHOH01REGNRegeneron Pharmaceuticals, Inc. · SpouseSell$1K–$15KOct 15, 202430dNov 14PDF
Josh GottheimerD-NJNJ05REGNRegeneron Pharmaceuticals, Inc. · JointSell$1K–$15KOct 23, 202414dNov 6PDF
Josh GottheimerD-NJNJ05REGNRegeneron Pharmaceuticals, Inc. · JointSell$1K–$15KJul 1, 202445dAug 15PDF
Greg LandsmanD-OHOH01REGNRegeneron Pharmaceuticals, Inc. · SpouseBuy$1K–$15KAug 11, 2023369dAug 14PDF
Tommy TubervilleSenateREGNRegeneron Pharmaceuticals, Inc. · JointSell$1K–$15KApr 4, 202441dMay 15Report
Josh GottheimerD-NJNJ05REGNRegeneron Pharmaceuticals, Inc. · JointSell$1K–$15KFeb 8, 202428dMar 7PDF
Jonathan JacksonD-ILIL01REGNRegeneron Pharmaceuticals, Inc. · JointBuy$1K–$15KJan 17, 202429dFeb 15PDF
Josh GottheimerD-NJNJ05REGNRegeneron Pharmaceuticals, Inc. · JointSell$1K–$15KNov 13, 202325dDec 8PDF
Josh GottheimerD-NJNJ05REGNRegeneron Pharmaceuticals, Inc. · JointBuy$1K–$15KAug 21, 202326dSep 16PDF
Josh GottheimerD-NJNJ05REGNRegeneron Pharmaceuticals, Inc. · JointBuy$1K–$15KJul 11, 202341dAug 21PDF
Josh GottheimerD-NJNJ05REGNRegeneron Pharmaceuticals, Inc. · JointSell$1K–$15KJun 22, 202319dJul 11PDF
Jonathan JacksonD-ILIL01REGNRegeneron Pharmaceuticals, Inc. · JointBuy$15K–$50KJun 23, 202314dJul 7PDF
Tommy TubervilleSenateREGNRegeneron Pharmaceuticals, Inc. · JointBuy$1K–$15KApr 3, 2023amendedMay 12Report
Tommy TubervilleSenateREGNRegeneron Pharmaceuticals, Inc. · JointBuy$1K–$15KApr 3, 202338dMay 11Report
Josh GottheimerD-NJNJ05REGNRegeneron Pharmaceuticals, Inc. · JointSell$1K–$15KMar 6, 202345dApr 20PDF
Thomas SuozziD-NYNY03REGNRegeneron Pharmaceuticals, Inc.Sell$1K–$15KAug 21, 20191216dDec 19PDF
Josh GottheimerD-NJNJ05REGNRegeneron Pharmaceuticals, Inc. · JointBuy$1K–$15KOct 19, 202222dNov 10PDF
Josh GottheimerD-NJNJ05REGNRegeneron Pharmaceuticals, Inc. · JointBuy$1K–$15KSep 12, 202234dOct 16PDF
Josh GottheimerD-NJNJ05REGNRegeneron Pharmaceuticals, Inc. · JointBuy$1K–$15KMay 5, 202242dJun 16PDF
Tommy TubervilleSenateREGNRegeneron Pharmaceuticals, Inc. · JointSell$1K–$15KMar 30, 20229dApr 8Report
Donald Sternoff BeyerD-VAVA08REGNRegeneron Pharmaceuticals, Inc. · JointSell$1K–$15KFeb 28, 20223dMar 3PDF
Donald Sternoff BeyerD-VAVA08REGNRegeneron Pharmaceuticals, Inc. · JointBuy$1K–$15KSep 17, 202114dOct 1PDF
Thomas SuozziD-NYNY03REGNRegeneron Pharmaceuticals, Inc.Sell$50K–$100KSep 16, 2019738dSep 23PDF
Thomas SuozziD-NYNY03REGNRegeneron Pharmaceuticals, Inc.Buy$50K–$100KMay 2, 2019875dSep 23PDF
Thomas SuozziD-NYNY03REGNRegeneron Pharmaceuticals, Inc.Sell$15K–$50KNov 7, 20181051dSep 23PDF
Thomas SuozziD-NYNY03REGNRegeneron Pharmaceuticals, Inc.Buy$15K–$50KNov 5, 20181053dSep 23PDF
Josh GottheimerD-NJNJ05REGNRegeneron Pharmaceuticals, Inc. · JointSell$1K–$15KJul 1, 202139dAug 9PDF
Donald Sternoff BeyerD-VAVA08REGNRegeneron Pharmaceuticals, Inc. · JointBuy$1K–$15KJul 21, 202117dAug 7PDF
Lisa MonacoDeputy Attorney General, Department of JusticeREGNRegeneron Pharmaceuticals, Inc.Sell$1K–$15KJul 15, 202122dAug 6PDF
Tommy TubervilleSenateREGNRegeneron Pharmaceuticals, Inc. · JointBuy$1K–$15KMar 29, 2021116dJul 23Report
Donald Sternoff BeyerD-VAVA08REGNRegeneron Pharmaceuticals, Inc. · JointBuy$1K–$15KJun 17, 202117dJul 4PDF
Josh GottheimerD-NJNJ05REGNRegeneron Pharmaceuticals, Inc. · JointSell$1K–$15KMay 17, 202129dJun 15PDF
Andrew SaulCommissioner, Social Security AdministrationREGNRegeneron Pharmaceuticals, Inc.Sell$100K–$250KFeb 11, 202141dMar 24PDF
Josh GottheimerD-NJNJ05REGNRegeneron Pharmaceuticals, Inc. · JointBuy$1K–$15KJan 11, 202129dFeb 9PDF
Gilbert CisnerosD-CACA39REGNRegeneron Pharmaceuticals, Inc.Buy$1K–$15KDec 22, 202020dJan 11PDF
Josh GottheimerD-NJNJ05REGNRegeneron Pharmaceuticals, Inc. · JointSell$1K–$15KDec 11, 202027dJan 7PDF
Donald Sternoff BeyerD-VAVA08REGNRegeneron Pharmaceuticals, Inc. · JointSell$1K–$15KAug 14, 202023dSep 6PDF
Donald Sternoff BeyerD-VAVA08REGNRegeneron Pharmaceuticals, Inc. · JointSell$1K–$15KJul 10, 202030dAug 9PDF
Dean PhillipsD-MNMN03REGNRegeneron Pharmaceuticals, Inc.Sell$1K–$15KMay 13, 202033dJun 15PDF
Josh GottheimerD-NJNJ05REGNRegeneron Pharmaceuticals, Inc. · JointBuy$1K–$15KMay 27, 202014dJun 10PDF
Donald Sternoff BeyerD-VAVA08REGNRegeneron Pharmaceuticals, Inc. · JointBuy$1K–$15KMay 20, 202011dMay 31PDF
Dean PhillipsD-MNMN03REGNRegeneron Pharmaceuticals, Inc.Sell$1K–$15KApr 2, 202035dMay 7PDF
Mikie SherrillD-NJNJ11REGNRegeneron Pharmaceuticals, Inc.Sell$1K–$15KFeb 20, 202045dApr 5PDF
Mikie SherrillD-NJNJ11REGNRegeneron Pharmaceuticals, Inc.Buy$1K–$15KJan 15, 202035dFeb 19PDF
Mikie SherrillD-NJNJ11REGNRegeneron Pharmaceuticals, Inc.Sell$1K–$15KDec 12, 201929dJan 10PDF
Josh GottheimerD-NJNJ05REGNRegeneron Pharmaceuticals, Inc. · JointBuy$1K–$15KNov 1, 201938dDec 9PDF
Josh GottheimerD-NJNJ05REGNRegeneron Pharmaceuticals, Inc. · JointSell$1K–$15KSep 20, 201921dOct 11PDF
Dean PhillipsD-MNMN03REGNRegeneron Pharmaceuticals, Inc.Buy$1K–$15KSep 11, 201930dOct 11PDF
Dean PhillipsD-MNMN03REGNRegeneron Pharmaceuticals, Inc.Buy$1K–$15KAug 13, 201934dSep 16PDF
Gilbert CisnerosD-CACA39REGNRegeneron Pharmaceuticals, Inc.Buy$1K–$15KAug 14, 201928dSep 11PDF
Michael McCaulR-TXTX10REGNRegeneron Pharmaceuticals, Inc. · SpouseSell$100K–$250KMay 7, 201951dJun 27PDF
Michael McCaulR-TXTX10REGNRegeneron Pharmaceuticals, Inc. · Dependent childSell$100K–$250KMay 7, 201951dJun 27PDF
Michael McCaulR-TXTX10REGNRegeneron Pharmaceuticals, Inc. · SpouseSell$100K–$250KMay 6, 201952dJun 27PDF
Michael McCaulR-TXTX10REGNRegeneron Pharmaceuticals, Inc. · Dependent childSell$100K–$250KMay 6, 201952dJun 27PDF
Dean PhillipsD-MNMN03REGNRegeneron Pharmaceuticals, Inc.Sell$1K–$15KMay 13, 201931dJun 13PDF
Michael McCaulR-TXTX10REGNRegeneron Pharmaceuticals, Inc. · SpouseSell$50K–$100KApr 23, 201922dMay 15PDF
Michael McCaulR-TXTX10REGNRegeneron Pharmaceuticals, Inc. · Dependent childSell$50K–$100KApr 23, 201922dMay 15PDF
Nicholas TaylorR-TXTX03REGNRegeneron Pharmaceuticals, Inc. · SpouseSell$15K–$50KMar 25, 201921dApr 15PDF
Nicholas TaylorR-TXTX03REGNRegeneron Pharmaceuticals, Inc. · SpouseSell$1K–$15KMar 7, 201939dApr 15PDF
Nicholas TaylorR-TXTX03REGNRegeneron Pharmaceuticals, Inc. · SpouseSell$1K–$15KFeb 6, 201936dMar 14PDF
Dean PhillipsD-MNMN03REGNRegeneron Pharmaceuticals, Inc.Buy$1K–$15KJan 4, 201945dFeb 18PDF
Nicholas TaylorR-TXTX03REGNRegeneron Pharmaceuticals, Inc. · SpouseSell$1K–$15KJan 22, 201924dFeb 15PDF
Michael McCaulR-TXTX10REGNRegeneron Pharmaceuticals, Inc. · SpouseSell$15K–$50KNov 8, 201844dDec 22PDF
Michael McCaulR-TXTX10REGNRegeneron Pharmaceuticals, Inc. · Dependent childSell$15K–$50KNov 8, 201844dDec 22PDF
Michael McCaulR-TXTX10REGNRegeneron Pharmaceuticals, Inc. · SpouseBuy$50K–$100KOct 18, 201828dNov 15PDF
Michael McCaulR-TXTX10REGNRegeneron Pharmaceuticals, Inc. · Dependent childBuy$50K–$100KOct 18, 201828dNov 15PDF
Gary PalmerR-ALAL06REGNRegeneron Pharmaceuticals, Inc. · SpouseSell$1K–$15KSep 18, 201821dOct 9PDF
Michael McCaulR-TXTX10REGNRegeneron Pharmaceuticals, Inc. · SpouseBuy$100K–$250KAug 6, 201837dSep 12PDF
Michael McCaulR-TXTX10REGNRegeneron Pharmaceuticals, Inc. · Dependent childBuy$100K–$250KAug 6, 201837dSep 12PDF
Michael McCaulR-TXTX10REGNRegeneron Pharmaceuticals, Inc. · SpouseSell$100K–$250KFeb 8, 201842dMar 22PDF
Michael McCaulR-TXTX10REGNRegeneron Pharmaceuticals, Inc. · Dependent childSell$100K–$250KFeb 8, 201842dMar 22PDF
Michael McCaulR-TXTX10REGNRegeneron Pharmaceuticals, Inc. · SpouseSell$50K–$100KFeb 7, 201843dMar 22PDF
Michael McCaulR-TXTX10REGNRegeneron Pharmaceuticals, Inc. · SpouseSell$50K–$100KFeb 6, 201844dMar 22PDF
Michael McCaulR-TXTX10REGNRegeneron Pharmaceuticals, Inc. · Dependent childSell$50K–$100KFeb 6, 201844dMar 22PDF
Michael McCaulR-TXTX10REGNRegeneron Pharmaceuticals, Inc. · SpouseSell$100K–$250KFeb 5, 201845dMar 22PDF
Michael McCaulR-TXTX10REGNRegeneron Pharmaceuticals, Inc. · Dependent childSell$100K–$250KFeb 5, 201845dMar 22PDF
Michael McCaulR-TXTX10REGNRegeneron Pharmaceuticals, Inc. · SpouseSell$15K–$50KDec 18, 201735dJan 22PDF
Michael McCaulR-TXTX10REGNRegeneron Pharmaceuticals, Inc. · Dependent childSell$15K–$50KDec 18, 201735dJan 22PDF
Sheldon WhitehouseD-RISenateREGNRegeneron Pharmaceuticals, Inc.Sell$15K–$50KDec 18, 201723dJan 10Report
Michael McCaulR-TXTX10REGNRegeneron Pharmaceuticals, Inc. · Dependent childBuy$50K–$100KNov 10, 201741dDec 21PDF
Michael McCaulR-TXTX10REGNRegeneron Pharmaceuticals, Inc. · Dependent childBuy$50K–$100KNov 6, 201745dDec 21PDF
Sheldon WhitehouseD-RISenateREGNRegeneron Pharmaceuticals, Inc.Buy$1K–$15KMay 16, 201723dJun 8Report
Sheldon WhitehouseD-RISenateREGNRegeneron Pharmaceuticals, Inc.Buy$1K–$15KSep 6, 201631dOct 7Report
Sheldon WhitehouseD-RISenateREGNRegeneron Pharmaceuticals, Inc.Buy$1K–$15KSep 6, 20163dSep 9Report
Sheldon WhitehouseD-RISenateREGNRegeneron Pharmaceuticals, Inc.Buy$1K–$15KMay 24, 201623dJun 16Report
Michael ConawayR-TXTX11REGNRegeneron Pharmaceuticals, Inc. · SpouseSell$1K–$15KFeb 26, 20165dMar 2PDF
Michael ConawayR-TXTX11REGNRegeneron Pharmaceuticals, Inc. · SpouseSell$1K–$15KJan 28, 201634dMar 2PDF
Steve ChabotR-OHOH01REGNRegeneron Pharmaceuticals, Inc.Buy$1K–$15KMay 26, 201530dJun 25PDF
Michael ConawayR-TXTX11REGNRegeneron Pharmaceuticals, Inc.Buy$1K–$15KFeb 9, 201522dMar 3PDF
Susan CollinsR-MESenateREGNRegeneron Pharmaceuticals, Inc. · SpouseSell$1K–$15KJan 30, 20146dFeb 5Report

Members who traded REGN

MemberTradesBuysSellsLast tradedLatest report
Michael McCaulR-TXTX1023617May 7, 2019Jun 27, 2019
Josh GottheimerD-NJNJ0521813Jan 24, 2025Feb 10, 2025
Donald TrumpPresident1073Jul 23, 2026Sep 22, 2026
Donald Sternoff BeyerD-VAVA08743Feb 28, 2022Mar 3, 2022
Dean PhillipsD-MNMN03633May 13, 2020Jun 15, 2020
Tommy TubervilleSenate532Apr 4, 2024May 15, 2024
Thomas SuozziD-NYNY03523Aug 21, 2019Dec 19, 2022
Sheldon WhitehouseD-RISenate541Dec 18, 2017Jan 10, 2018
Gilbert CisnerosD-CACA31431May 15, 2026Jun 8, 2026
Jonathan JacksonD-ILIL01422Nov 13, 2024Dec 12, 2024
Nicholas TaylorR-TXTX03404Mar 25, 2019Apr 15, 2019
Rob BresnahanR-PAPA08312May 15, 2025Jun 9, 2025
Julie JohnsonD-TXTX32312Apr 1, 2025May 14, 2025
Mikie SherrillD-NJNJ11312Feb 20, 2020Apr 5, 2020
Michael ConawayR-TXTX11312Feb 26, 2016Mar 2, 2016
Bryan BedfordAdministrator, Federal Aviation Administration, Department of Transportation211Sep 10, 2025Dec 19, 2025
Byron DonaldsR-FLFL19202Apr 10, 2025May 24, 2025
Greg LandsmanD-OHOH01211Oct 15, 2024Nov 14, 2024
Alan ArmstrongR-OKSenate110Mar 27, 2026Jul 21, 2026
Rohit KhannaD-CACA17101Jun 2, 2026Jul 6, 2026
Julia LetlowR-LALA05110Feb 12, 2026Mar 12, 2026
Jefferson ShreveR-ININ06101Apr 7, 2025May 8, 2025
Lisa MonacoDeputy Attorney General, Department of Justice101Jul 15, 2021Aug 6, 2021
Andrew SaulCommissioner, Social Security Administration101Feb 11, 2021Mar 24, 2021
Gary PalmerR-ALAL06101Sep 18, 2018Oct 9, 2018
Steve ChabotR-OHOH01110May 26, 2015Jun 25, 2015
Susan CollinsR-MESenate101Jan 30, 2014Feb 5, 2014

Source

Each trade is a line of a periodic transaction report filed under the STOCK Act, read from the report itself and linked to it. Three offices publish them, and all three are read here every hour: the House Clerk for representatives, the Senate Office of Public Records for senators, and the Office of Government Ethics for the President, the Vice President and Senate-confirmed officials (OGE Form 278-T). OGE links some officials’ reports and releases the rest on request; only linked reports are here.

The Act requires a report within 45 days of the trade; the lag counts the days from the trade to the day the report became public. Reports give each amount as a range. Amendments are marked and not counted as late; trades a later report withdrew are left out. The President’s reports and some House reports are scans of paper forms: a scanned value that does not read with certainty is shown as not read, never guessed, and the report is one click away. “Since” is the stock’s move from the trade date’s close to the latest daily close.

The same trades are in the OptimistFi MCP server’s get_congress_trades tool, by filer or by stock, for each chamber: connect it. Every House trade is free to download as CSV or JSON, and every trade here can be followed by RSS: the data.

ScoutJUST THIS STORY

LET’S MAKE THIS USEFUL · 1 OF 5

How would you like me to explain this?

Tell me what you want from this read. Start with a quick note, then adjust the details. Your other stories stay as they are.

We’ll remember your view of this story. The published article stays unchanged.

THIS STORY’S READING VIEWStandard · The whole picture

Clear explanations with context. Both sides of the evidence.